(INNF)
ANVATABART PACTIL(INNS)
ANVATABART PACTIL(INND)
ANVATABART-PAKTIL(INNC)
IMMUNOGLOBULIN G1-KAPPA, ANTI-[HOMO SAPIENS ERBB2 (EPIDERMAL GROWTH FACTOR RECEPTOR 2, RECEPTOR TYROSINE-PROTEIN KINASE ERBB-2, EGFR2, HER2, HER-2, P185C-ERBB2, NEU, CD340)], HUMANIZED MONOCLONAL ANTIBODY, CONJUGATED AT TWO ENGINEERED PHENYLALANINE SITES WITH P-ACETYL GROUPS; GAMMA1 HEAVY CHAIN HUMANIZED (1-449)[VH HUMANIZED (HOMO SAPIENS IGHV3-66*01 (81.6%) -(IGHD) -IGHJ4*01 (100%), CDRIMGT [8.8.13] (26-33.51-58.97-109)) (1-120) -HOMO SAPIENS IGHG1*01, G1M17,1 (CH1 A1.4>F (PAF) (121), K120 (217) (121- 218), HINGE 1-15 (219-233), CH2 (234-343), CH3 D12 (359), L14 (361) (344-448), CHS K2>DEL (449)) (121-449)], (223-214')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-214') [V-KAPPA (HOMO SAPIENS IGKV1-39*01 (86.3%) -IGKJ1*01 (100%), CDR-IMGT [6.3.9] (27- 32.50-52.89-97)) (1'-107') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (153), V101 (191) (108'-214')]; ... PROPOSED INN: LIST 127(WHO)